Kao Corporation (TYO:4452)
Japan flag Japan · Delayed Price · Currency is JPY
3,525.00
+337.00 (10.57%)
Aug 6, 2026, 9:55 AM JST

Kao Corporation Earnings Call Transcripts

Fiscal Year 2026

  • Status update

    AI is transforming the customer journey, requiring brands to focus on scientific evidence and trusted quality to be recommended by AI agents. Global Marketing i-Kao enables real-time, data-driven marketing, while organizational changes and regional DX centers drive global growth and profitability.

  • Q1 saw strong sales and profit growth, with operating income up JPY 14 billion year-over-year and robust gains in Japan's GC Business. Full-year guidance is maintained despite external risks, and profit recovery is expected in Chemicals from Q2.

Fiscal Year 2025

  • Fiscal 2025 delivered strong sales and profit growth, with improved margins and ROIC, driven by robust performance in Japan and recovery in key overseas segments. Fiscal 2026 guidance projects continued growth, supported by new product launches, digital transformation, and strategic capital allocation.

  • Earnings for the nine months ended September 2025 showed strong sales and profit growth, with operating margin and ROIC both at 9.3%. Cosmetics and GC businesses led recovery, while cost controls and price increases offset raw material pressures.

  • Status update

    Aims to become the top choice in targeted cosmetics segments by 2027 through global brand focus, operational efficiency, and digital transformation. Targets include JPY 300 billion in sales and 7% operating margin, driven by six focus brands and strategic market expansion.

  • Solid first-half results led to upward revisions in full-year forecasts for sales and operating income, driven by strong performance in Japan, successful product launches, and ongoing structural reforms. Share repurchase and improved capital efficiency further support growth ambitions.

  • First quarter saw strong sales and margin growth, with operating income up 38.7% year-over-year. Cosmetics and UV Care segments drove performance, while tariff and raw material risks are being actively managed. Full-year guidance is maintained.

Fiscal Year 2024

  • Strong profit recovery in 2024 was driven by higher value-added products, cost reductions, and improved brand loyalty, with all key metrics exceeding expectations. 2025 guidance anticipates continued growth, especially in cosmetics and global expansion, despite rising raw material costs and ongoing challenges in China.

  • Structural reforms and high-value-added product strategies drove strong profit and margin growth, with ROIC up 4.9 points and operating income up 42.8% year-over-year. China cosmetics remains a drag, but gains from business transfers and global expansion support positive outlook.

  • First-half profit surged 68% year-over-year, driven by structural reforms and high-value-added products, with strong gains in core brands and chemicals. Full-year operating income forecast was raised to JPY 140 billion, but China cosmetics remain a drag.

  • Status update

    Digital investment will shift from core systems to DX advancement by 2027, with a focus on operational efficiency and value creation. Key strengths include the i-Lake data platform, citizen developers, and global upskilling. Initiatives like My Kao and precision monitoring drive customer engagement and global expansion.

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021